313: Dalgleish A, Whelan M. Novel immunotherapeutic approaches to prostate
cancer. Curr Opin Mol Ther. 2005 Feb;7(1):30-4. Review. PubMed PMID: 15732527.


314: Dalgleish AG. Therapeutic cancer vaccines: why so few randomised phase III
studies reflect the initial optimism of phase II studies. Vaccine. 2011 Nov
3;29(47):8501-5. doi: 10.1016/j.vaccine.2011.09.012. Epub 2011 Sep 18. Review.
PubMed PMID: 21933695.


315: Dalgleish AG, Whelan MA. Cancer vaccines as a therapeutic modality: The long
trek. Cancer Immunol Immunother. 2006 Aug;55(8):1025-32. Epub 2006 Feb 28.
Review. PubMed PMID: 16506069.


316: Dalgleish AG. Cancer vaccines as a therapeutic strategy. Expert Rev
Vaccines. 2004 Dec;3(6):665-8. PubMed PMID: 15606350.


317: Dalgleish AG, Perry MJ, Eaton JD, Hrouda D, Todryk SM, Kirby RS. The
immunotherapy of prostate cancer. Prostate Cancer Prostatic Dis. 2000
Dec;3(4):303-307. PubMed PMID: 12497083.